Zurich Cantonal Bank’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,831
Closed -$405K 2958
2022
Q3
$405K Hold
7,831
﹤0.01% 1328
2022
Q2
$194K Sell
7,831
-88
-1% -$1.94K ﹤0.01% 1811
2022
Q1
$199K Sell
7,919
-1,615
-17% -$45.4K ﹤0.01% 1887
2021
Q4
$347K Buy
9,534
+3,734
+64% +$131K ﹤0.01% 1716
2021
Q3
$99K Hold
5,800
﹤0.01% 2346
2021
Q2
$78K Hold
5,800
﹤0.01% 2318
2021
Q1
$297K Sell
5,800
-760
-12% -$45.7K ﹤0.01% 1552
2020
Q4
$406K Buy
6,560
+2,162
+49% +$124K ﹤0.01% 1397
2020
Q3
$241K Hold
4,398
﹤0.01% 1470
2020
Q2
$253K Buy
4,398
+1,812
+70% +$98.6K ﹤0.01% 1379
2020
Q1
$104K Hold
2,586
﹤0.01% 1591
2019
Q4
$102K Buy
2,586
+1,467
+131% +$25.8K ﹤0.01% 1710
2019
Q3
$8K Hold
1,119
﹤0.01% 2575
2019
Q2
$10K Buy
+1,119
New +$13K ﹤0.01% 2571

Other funds holding CCXI

Zurich Cantonal Bank's CCXI Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,831 shares — an estimated $405K sold.

Zurich Cantonal Bank first reported a position in CCXI in Q2 2019 and held it in 14 quarters. The position peaked at $406K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 7,831 ChemoCentryx, Inc. shares in Q4 2022, an estimated $405K.
  • Zurich Cantonal Bank first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 14 quarters.
  • Zurich Cantonal Bank's ChemoCentryx, Inc. position peaked at $406K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.